Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
n. orhan ozer (istanbul, Turkey), E. Niksarlioglu (istanbul, Turkey), E. Altundas Hatman (istanbul, Turkey), A. Yeter (istanbul, Turkey), E. Sahin (istanbul, Turkey), G. Çamsari (istanbul, Turkey). Relapse ratios and factors affecting relapse in sarcoidosis patients that are followed at least 5 years.. 3007

Member's Comments

No comment yet.

Related content which might interest you: The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up) Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Childhood factors associated with complete and clinical asthma remission at 25 and 49 years Source: Eur Respir J, 49 (6) 1601974; 10.1183/13993003.01974-2016 Year: 2017 The analysis of lung cancer patients (LCP) survival during 5 year period after diagnosis of disease Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006 Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 TB re-treatment results in relapses, default and failure – cohort study for 7 years Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis Year: 2006 Asthma; gender differences in incidence and remission from 10 to 16 years? Source: Annual Congress 2010 - Risk factors for allergic diseases in children Year: 2010 Study of risk factors in relapses at patients with pulmonary tuberculosis. Their retreatment results Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001 Prognosis in chronic cough at 3 and 6 monts of follow-up according the presence of aggravating factors Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 Different mortality, recurrence and bleeding between cancer and non cancer patients with pulmonary embolism (PE): 1 year follow-up. Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Analysis of cases from an interstitial lung disease (ILD) MDT in a teaching hospital in the West Midlands: Patients with smoking-related disease comprise 11% of cases and have a median age of 50 years Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011 Patterns of drug resistance at initiation of re-treatment across relapse, default and failure subcategories in previously treated tubercular patients Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Risk factors associated with treatment interruption for 2 months among tuberculosis patients in Taipei Source: Annual Congress 2007 - Tuberculosis control Year: 2007 Factors affecting the duration from diagnosis to treatment in patients with lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 668s Year: 2007 Early lower airway infection: risk factors for asthma at age of 14-16 years Source: Eur Respir J 2004; 24: Suppl. 48, 717s Year: 2004 The risk of tuberculosis disease among HIV infected patients after 2 years of follow up Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 The influence of metabolic syndrome in mortality rate of COPD patients: A five years follow up study Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Pathophysiological risk factors for chronization of bronchitis in children aged 7-10 years Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008 Predicted factors of radiographic sequelae in tuberculosis treated patients. Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 One-year survival in patients hospitalized due to an acute exacerbation of COPD. Related factors Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009